Stimwave LLC has received FDA 510(k) clearance for the first wireless, micro-technology neuromodulation device that can enable ongoing full-body MRI scans under certain scanning conditions for the relief of chronic peripheral nerve pain. Designed for people who suffer from severe intractable chronic pain, the StimQ Peripheral Nerve Stimulator (PNS) System offers an alternative for those who do not want to rely on invasive surgical procedures or ongoing opioid treatments. Stimwave LLC is headquartered in Pompano Beach, FL.
Indications: The device, which is less than 5% of the size of other standard implanted options, provides pain relief by delivering small pulses of energy in a fully-selectable manner to electrodes placed at a peripheral nerve enabling the brain to remap specific pain signals. The implant is powered by a small, flexible and comfortable wearable external unit.
Administration: The StimQ device can be used in a minimally-invasive, outpatient procedure for the treatment of various pain syndromes, including, but not limited to: shoulder pain, upper extremity neuropathy, mid and lower back pain, and lower extremity neuropathy. The recent FDA clearance enables the pain sufferer to have frequent and necessary MRI scans of any part of their body without removing the implant.
Stimwave receives FDA 510(k) clearance for the first full-body MRI scan ready wireless peripheral nerve stimulator (PNS) system. [news release]. Pompano Beach, Florida. August 9, 2017. http://www.pharmalive.com/stimwave-receives-fda-510k-clearance-for-the-f.... Accessed August 15, 2017.
This Week's Must Reads
AD, Rest-Activity Rhythm Fragmentation Linked , JAMA Neurology; ePub 2018 Jan 29; Musiek, et al
Psychiatric Disease, Lower Rates of IVT Linked, Stroke; ePub 2018 Jan 26; Bongiorno, et al
Stroke Care Disparities in US Military Healthcare, J Neurolog Sci; ePub 2018 Jan 17; Blattner, et al
Setting Plays Role in Evaluating Cognitive Decline, Alzheimers Dement; ePub 2018 Jan 17; Snitz, et al
Incidence of Periictal Apnea in Epileptic Seizures, Epilepsia; ePub 2018 Jan 16; Lacuey, Zonjy, et al
Must Reads in FDA Actions
Riptide Aspiration System Receives FDA Clearance, Medtronic news release; 2018 Jan 16
FDA Approves Vercise Deep Brain Stimulation System, Boston Scientific news release; 2017 Dec 11
FDA Approves Repatha to Prevent Stroke, Heart Attack, Amgen news release; 2017 Dec 1
FDA Clears Apple Watch Heart Rate Accessory, PharmaLive news release; 2017 Nov 30
FDA Approves Oral Option for Pediatric Epilepsy, UCB news release; 2017 Nov 6